Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Scientists at University of Cambridge, Department of Pathology detail research in life sciences
June 25th, 2008
Researchers detail in 'Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide,' new data in life sciences. According to recent research from Cambridge, the United Kingdom, "Cyclophosphamide (CTX) is an alkylating cytotoxic drug that primarily affects proliferating lymphocytes. CTX has been extensively used as a chemotherapeutic and disease-modifying agent against certain solid tumors, lymphomas, and some autoimmune conditions." "Depending on its dose and timing of administration, CTX can also enhance immune responses. These opposing immune functions of CTX have been investigated in numerous animal models and recent clinical studies. Administration of...
Source: Vaccine Weekly (2008-06-25)
|
